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Abstract Background/Objectives: 
Pneumonia is a leading cause of 
morbidity and mortality in chil-
dren and thus this study was de-
signed to document the sociode-
mographic, clinical features as 
well as the bacterial agents re-
sponsible for pneumonia in chil-
dren seen at University of Ilorin 
Teaching Hospital. 
Methodology: A descriptive cross
-sectional study of children aged 
one month to 14 years with fea-
tures of pneumonia admitted be-
tween July 1st 2010 and June 31st, 
2011 was carried out. Socio-
demograpic data, clinical features, 
complications and outcome were 
obtained. Chest radiographs and 
blood samples for culture of bac-
terial organism and full blood 
counts were obtained in all chil-
dren. 
Results: Pneumonia accounted for 
13.3% (167 out of 1254) of the all 
admissions during this period. 
The male: female ratio was 1.5:1, 
and 101(60.5%) of the children 
were infants. Bronchopneumonia 
was identified in 147(88%)  
children, lobar pneumonia in 15
(9%) while 5(3%) had a combina-
tion of both.  Cough, fever, diffi-
culty in breathing, tachypnoea and 
chest wall recessions were recog-
nised as clinical features in the 
study population. Bacteraemia was 
present in 46(27%)children and 
Staphylococcus aureus was the 
most common organism cultured 
from the blood of children with 
pneumonia present in 11 (23.9%) 
out of the 46 (100.0%) isolates. 
Heart failure was associated com-
plication present in 52 of the 60 
children with one or more compli-
cations accounting for over 30% of 
all patients. Eleven out of the 15 
children with lobar pneumonia had 
pneumonia-related complications 
which was significantly higher 
compared to 46 of 157 children 
with bronchopneumonia, p=0.003. 
The case fatality was 6.6%. Eight 
(72.7%) of the children that died 
were infants while the remaining 
three (27.3%) were aged between 
12 and 60 months. The mean dura-
tion of hospitalization among those 
who survived of 6.5 ±5.0 days was 
significantly lower than the corre-
sponding value of 10.2 ±12.3 days 
in those that died, p= 0.042.   
Conclusion: Pneumonia-related 
mortality and morbidity is high in 
under-five children, with the infant 
age group most affected. Broncho-
pneumonia is the most prevalent 
ALRI diagnosis but lobar pneumo-




Pneumonia continues to be a major contributor to child-
hood mortality and morbidity in developing countries 
including Nigeria.1,2  Pneumonia is responsible for a 
quarter of all deaths in under-five children. Many of the 
deaths occur in those less than 24 months especially in 
infants.1 A number of aetiologic agents, viruses and bac-
teria, have been associated with pneumonia, however it 
is the bacterial agents that are usually associated with 
severe pneumonia and result in complications or deaths. 
Streptococcus pneumonia and Haemophilus Influenzae 
remain the most important pathogens documented in 
previous studies.3-6Staphylococcus has also been found 
especially in patients with malnutrition.8,9 A few studies 
in Africa have documented the presence of nontyphoidal 
salmonella in patients with radiologically confirmed 
severe pneumonia.10,11 A number of conditions such as 
malnutrition, sickle cell anaemia and Human Immune 
deficiency virus infection can affect the severity and 
outcome of pneumonia cases.8,9,11-13 Pneumonia is the 
second cause of admission and deaths among children 
seen at the University of Ilorin Teaching hospital 
(UITH). 14 
The challenge of inadequate and supportive laboratory 
services in developing countries cannot be overempha-
sized, hence it is important to follow disease burden in 
the community and in hospital settings using clinical 
features and parameters less reliant on the laboratory. 
This study was designed to document the sociodemo-
graphic data, clinical features as well as the bacterial 
agents responsible for pneumonia in children seen at 
University of Ilorin Teaching Hospital between 1st July 
2010 and 30th June 2011. The outcome in all cases was 





Materials and Method 
Study Design  
 
This was a prospective, cross-sectional, mainly descrip-
tive study of children aged one month to fourteen yars 
who were admitted to the Emergency Paediatric Unit 
(EPU) of the UITH which serves the state population of 
2.4 million11    and adjoining states of Ekiti, Osun, Oyo 
and Niger. 
 
Sample size  
 
The formula used for estimating the minimum sample 
size is the Fisher’s formula 15 and with reference to the 
prevalence of 11.1% from a previous study,16 a mini-
mum total of 151 subjects were recruited for the study 





Ethical clearance was duly obtained from the Ethics and 
Research Committee of the UITH. In addition, informed 
consent was obtained from the individual parent/
guardian or subject as appropriate, after a clear explana-




All consecutive children who presented at the EPU of 
UITH initially with symptom complex of pneumonia, 
with or without features of measles or pertussis and in-
trathoracic complications like pleural effusion, in a child 
presenting with cough, fever, difficulty with breathing 
of less than 28 days duration with (a) age-specific in-
crease in respiratory rate(tachypnoea) (b) lower chest 
wall indrawing (c) inability to feed or drink, with or 
without central cyanosis.17 All subjects had chest radio-
graphs and the presence of one or more of the chestra-
diographic features of patchy, segmental or lobar con-
solidation, +/- a positive air bronchogram and +/- pleural 
effusion was used to confirm the diagnosis. The radio-
graphic findings were corroborated by at least one radi-
ologist. All subject recruitment was done at presenta-
tion. Children that had previously been recruited for the 
study who re-present to the unit with symptom recrudes-
cence are excluded from the study. 
All subjects had blood specimen obtained for blood cul-
ture and total blood counts. Other relevant tests such as 
haemoglobin electrophoresis, HIV screening and pleura  
fluid analysis were done only when indicated. The sub-
jects were treated with the most appropriate medication 
according to the current institutional guidelines. 
 
Data was collected with the aid of a pre-coded study 
proforma and analysis was carried out with a micro-
computer using the Epi info version 6.0 software pack-
ages. The chi-square and student t-tests were used to 
identify significant differences for categorical and con-







Background characteristic of study population 
During the study period, a total of 1254 patients were 
admitted to the EPU and 167 (13.3%) were diagnosed 
with pneumonia. Of these recruited 167 subjects, 101
(60.5%) were infants and 80.3% were below 24 months.  
The mean age of the subjects was 14.8±16.1 months, 
with a range of 1-110 months. The Male: Female ratio 
was 1.5:1. The distribution of the social class of the chil-
dren with pneumonia using classification modified by 
Ogunlesi et al 18 is as shown in Table 1 with 40 (24.0%) 
in social classes I and II and 127(76.0%) in the lower 
three social classes. 
 
Table 1: Sociodemographic data of study population 
Clinical features of the patients with pneumonia 
Symptoms at presentation 
 
Fever was present in 129 (77.2%) of the children, while 
cough was present in 115 (68.9%) of the children as the 
single most common respiratory symptom. Table 2  
below shows other constitutional and respiratory symp-
toms that were present in patients recruited during the 
study. The duration of symptoms at presentation ranged 
from one day to 10 days. The duration of symptoms in 
Variable Frequency Percentage Cumulative percent 
Age (months)       
1-<12 101 60.5 60.5 
12- <24 33 19.8 80.3 
24- <36 17 10.2 90.5 
36-<48 7 4.1 94.6 
48<60 3 1.8 96.4 
>60 6 3.6 100.0 
Gender       
Male 100 59.9 59.9 
Female 67 40.1 100.0 
Social Class       
SCI 16 9.6 9.6 
SCII 24 14.4 24.0 
SCIII 60 35.9 59.9 
SCIV 44 26.3 86.2 
SCV 23 13.8 100.0 
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101(60.6%) children was of three or less days before 
presentation, 46 (27.6%) children had symptoms for 4-7 
days, while  20 (12.0%) had symptoms for 8 days or 
more. 
 
Table 2: Symptoms at presentation 
Physical Signs at presentation 
 
 Eight (4.8%) children had an axillary temperature re-
cording of less than 36.5oC, 33 (19.8%) recorded tem-
peratures between 36.5 to 37.4 oC, 70 (41.9%) between 
37.5 and 38.5 oC, while 56 (33.5%) children recorded 
temperature readings of more than 38.5 oC. Six (3.6%) 
children were lethargic while two (1.2%) were irritable, 
five (3%) were unconscious. Three (1.8%) children had 
a maculopapular rash. Ninety-six (57.5%) of the chil-
dren were well hydrated, sixty-four (38.3) were dehy-
drated, and seven were unspecified. The respiratory 
signs present include tachypnoea in 143 (85.6%), crepi-
tations in 154 (92.2%), thoracic recessions in 133 
(79.6%), nasal flaring in 134 (80.2%), and diminished 
breath sounds in 89 (53.4%). These findings are shown 
in table 3.   
 
Table 3: Distribution of physical signs in children with  
Pneumonia 
Signs    Frequency (%) 
 
Crepitations   154 (92.2%) 
Tachypnoea   143 (85.6%) 
Nasal flaring   134 (80.2%) 
Thoracic recessions   133 (79.6%) 
Diminished BS   89 (53.4%) 
Grunting    53 (31.7%) 
Abnormal percussion note  29 (17.4%) 
Central cyanosis   13 (7.8%) 
Tracheal deviation   7 (4.2%) 
Bronchial BS   6 (3.6%) 




Bronchopneumonia accounted for 147 (88.0%), Lobar 
pneumonia 15 (9%), and 5 (3%) had a combination of 
bronchopneumonia and lobar pneumonia. The diagnosis 
in study subjects is displayed below with respect to he 
age group 
Variable Frequency % Cumulative   
% 
Constitutional symptoms       
Fever 129 77.2 77.2 
Diarrhoea 24 14.4 91.6 
Vomiting 6 3.6 95.2 
Rashes 4 2.4 97.6 
Others (convulsion, 
altered consciousness) 4 2.4 
  
100.0 
Respiratory symptom       
Cough 115 68.9 68.9 
Difficult breathing 42 25.1 94.0 
Noisy breathing 6 3.6 97.6 
Fast breathing 
  
4 2.4 100.0 
  
  
Table 4: Diagnosis by age groups 
Bacteraemia in children with pneumonia 
 
Forty-six (27.5%) children with pneumonia had positive 
blood cultures, while 121 (72.5%) children had blood 
cultures which yielded no growth. 39 (25%) of the 156 
children with a full recovery from the pneumonia had 
bacteraemia which compared with 7 (63.6%) of the 11 
children with pneumonia who died had bacteraemia was 
significant, p=0.011.  
 
Organisms in children with pneumonia 
 
Staphylococcus aureus was cultured from the blood of 
11 (23.9%) out of the 46 (100.0%) children with posi-
tive culture. Klebsiella species was isolated in 8 
(17.4%); coliforms and coagulase negative staphylococ-
cus in 7 (15.2%) each; micrococcus and non-haemolytic 
streptococcus were the least common yield, each present 
in three (6.5%) isolates. A mixed growth was isolated in 




A total of 60 (35.9%) cases developed one or more cm-
plications. Heart failure was seen in 52 (86.7%) of the 
60 children with one or more complications making 
31.1% of the 167 subjects recruited. Five patients (3%) 
each had pleural effusion and pneumothorax, 4 (2.4%) 
had acute renal failure and all these patients had vomit-
ing and diarrhoea. Three (1.8%) had hypoglycaemia.  
Eleven (73.3%) out of the 15 children with lobar pneu-
monia had pneumonia-related complications compared 
to 46 (29.3%) of 157 children with bronchopneumonia, 
p=0.003.  
Five (45.5%) of 11 children with lobar pneumonia with 
complication had more than one pneumonia-related 
complication which was significantly higher compared 
to seven (15.2%) with more than one complication 
among the 46 children with bronchopneumonia who had 
pneumonia-related complication, p=0.045 (see table 5) 
Co-morbidities in the children with pneumonia included 
measles present in 4 (2.4%) children, underlying  
congenital heart disease in 6 (3.6%) children, three of 
whom had Down’s syndrome, and 11 (6.6%) had HIV 
infection  
  
Variable Bronchopneumonia LP BP + LP 
Age (months) No (%) No (%) No (%) 
1-<12 90 (53.9%) 9 (5.4%) 2 (1.2%) 
12- <60 52 (31.1%) 6 (3.6%) 2 (1.2%) 
>60 5 (3.0%) 0 1 (0.6%) 
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Table 5: Complication based on type of pneumonia 
a: compares BP with a combination of LP and BP+LP 
*: Fischers Exact test 
 
Outcome of pneumonia 
 
A case fatality of 6.6% (11 deaths) was recorded in this 
study. One hundred and fifty-six (93.4%) recovered 
from the illness. Ten (90.9%) of the children that died 
were male, while one (9.1%) was a female. Eight 
(72.7%) of the children that died were infants while the 
remaining three (27.3%) were aged between 12 and 60 
months. 
 
Outcome based on diagnosis and presence of  
complications  
 
A percentage mortality of 13.3% was recorded among 
children with lobar pneumonia compared to the 6.1% 
mortality recorded in those with bronchopneumonia. 
The difference was not however statistically significant, 
p=0.469 as shown in table 6. 
A mortality of 13.3% was recorded in those with pneu-
monia-related complication compared to the mortality of 
2.8% recorded in those who had no pneumonia-related 
complication at presentation. This contrast was signifi-
cant statistically at p=0.018 as also seen below in table 
6. 
 
Table 6: Outcome based on diagnosis and presence of compli-
cations 
Duration of hospitalization among children with  
Pneumonia 
 
The overall mean duration of hospitalization among the 
children with pneumonia was 6.8±5.8 days. The mean 
duration of hospitalization among those who survived of 
6.5 ±5.0 days was significantly lower than the  
corresponding value of 10.2 ±12.3 days in those that
died, p= 0.042.   






BP + LP 
N 
P 
Complication         
Present 46 11 3 0.003 
Absent 101 4 2   
No. of complication         
One 39 6 2 0.045*a 







Fisher exact derived 
p-value 
Diagnosis       
Bronchopneumonia 138(93.9) 9(6.1) 0.469 
Lobar pneumonia 13(86.7) 2(13.3)   
BP + LP 5(100.0) 0(0.0)   
Complication       
Present 52(86.7) 8(13.3) 0.018 
Absent 104(97.2) 3(2.8)   
No. of complication       
None 104(97.2) 3(2.8) 0.009 
One 42(89.4) 5(10.6)   
More than one 10(76.9) 3(23.1)   
Discussion 
 
Pneumonia is a leading cause of disease and death 
among children worldwide and the greatest burden of 
disease is in Under Fives in developing countries, n-
cluding Nigeria.1,2 At the study site, pneumonia consti-
tuted close to 15% of all paediatric admissions through 
the EPU over a 12 month period. Pneumonia affects the 
extremes of life more than other age groups as was 
documented in this study where two third of all patients 
were infants and 80% were below 24 months. The  
lowest three social classes were affected most by the  
disease. These findings are in agreement with those of 
previous workers. 3,7, 12,16 It therefore means that  
measures for the control of pneumonia in childhood 
must focus on the first four years of life. 
 
In developing countries, the operational definition f 
pneumonia adopted by WHO are based on easily recog-
nisable clinical parameters- signs and symptoms- and 
said to be reliable for diagnosing the disease.5,17, The 
most frequent constitutional symptom in the current 
study population was fever which was present in more 
than three quarter of the cases. Diarrhoea was found in 
15% and this reflects the immunologic nature of the gut 
especially in children.20,21 The paucity of cases with rash 
(case definition for measles was used) was because of 
the successful measles vaccination campaigns that domi-
nated the last three years before the study.22 this is in 
contrast with the findings of earlier workers in Ibadan 
who found measles to be a significant association in 
pneumonia cases.8 Cough and difficulty in breathing are 
the main respiratory symptoms documented. The main 
respiratory signs were tachypnoea, nasal flaring, chest 
wall recessions and crepitations. These clinical parame-
ters except for crepitations are indeed useful for diagno-
sis of pneumonia at all levels of health care in develop-
ing countries.5,17 The use of cough and difficult/fast 
breathing for identifying and treating or referring cases 
at primary and secondary levels must be strengthened 
using the Integrated management of childhood illnesses 
(IMCI) guidelines.23 This will help reduce delays in 
treatment/referral and also reduce complications.  
Consequently, death and hospitalizations from pneumo-
nia will reduce. Furthermore, where adequate microbo-
logic support is not available, non-aetiologically proven 
disease burden of pneumonia can be followed in devel-
oping countries using these clinical parameters. This is 
indeed important as Nigeria moves to introduce Haemo-
philus influenzae and pneumococcal vaccines into the 
routine immunization programme.    
 
Bacteraemia was found in 27.5% of all cases and this is 
comparable to the findings of earlier workers.24-26 
Staphylococcus aureus, was the most commonly iso-
lated organism and this finding is similar to the findings 
of earlier workers in Ilorin and elsewhere.8,16 And to-
gether with Klebsiella species (these were not charac-
terised further because of laboratory constraints) these 
two organisms formed more than 40% of the isolates. 
Significant number of coliforms and coagulase negative 
staphylococcus were also isolated. In contrast to some 
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workers in Nigeria and other developing countries, 
Streptococcus pneumoniae, Haemophilus influenzae, 
Salmonella typhi and non-typhoidal salmonella were not 
documented in this study.6,10,13,24,25,27  The absence of 
two key organisms of pneumonia, Streptococcus pneu-
moniae and Haemophilus influenzae, from the isolates 
profile is most likely a reflection of the limited micro-
biologic support for the isolation of these organisms at 
the study site. However, extrapolated data from similar 
settings referenced above provide evidence of the impor-
tance of these organisms in causing invasive childhoo  
diseases and pneumonia, and the need for collaboration 
between study sites. Bacteraemia was associated with 
increased mortality in the study population. This is more 
a consequence of the major organisms isolated in this 
study which result in severe disease. 
 
Bronchopneumonia was the most common form of dis-
ease found in our patients and the most frequent compli-
cation in the group studied was heart failure. This is 
consistent with the findings of other workers.5, 11, 15-
16.Other potentially life-threatening complications seen 
in the cases were hypoglycaemia and renal failure in 
patients who had diarrhoea and vomiting.  Management 
of patients with pre-renal renal failure and pneumonia 
can present challenges with fluid therapy as adequat  
renal perfusion needs to be achieved quickly.  Pleura  
effusion and pneumothorax were seen in a few cases. 
The presence of complications was associated with sig-
nificantly higher morbidity and mortality and must be 
managed at specialist centres. There were co-morbid 
conditions in more than 10% of the cases. Measles, HIV 
infection, congenital heart diseases with or withou 
Down’s syndrome were the associated conditions.   
 
 In Nigeria, the standard management plans to identify 
and treat children must be followed to reduce the risk of 
complications. Capacity building of different cadres of 
health care workers will ensure prompt treatment/
referral; hence reduce the chances of complications and 
death. Sustainable and widely accessible immunization 
programme that will control vaccine-preventable dis-
eases such as measles, tuberculossis and pertussis, a  
well as the inclusion of Streptococcus pneumoniae nd 
Haemophilus influenzae antigens in the given vaccines, 
will also see the prevention of diseases associated with 
these organisms. The emergence of a St phylococcus 
aureus vaccine will be a welcome addition to the meas-
ures against pneumonia in the near future. There is a 
need to improve the socioeconomic status of many fami-
lies in order to reduce the risk of disease. The ned for 
health systems strengthening in order to improve aetio-
logical diagnosis of pneumonia; institutionalize disease 
surveillance, and monitor and supervise all control and 
prevention activities cannot be overemphasized. It is 
only with these approaches that pneumonia associated 
mortality and morbidity can be averted.   
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